Asia is currently on track to become the epicenter of growth in biopharmaceuticals and medical devices. This book accounts for the regional rise of these industries with a conceptual framework that considers how national governments have managed key factors, like innovative capacity, government policy, and the firm-level strategies in China, India, Japan, and Singapore. What emerges is an argument that countries which encouraged a global mindset in these target industries, while pursuing a more traditional, nationalistic agenda within the domestic economy, have been most successful.